Add
CNDO to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| CNDO > SEC Filings for CNDO > Form 8-K on 26-Jun-2012 | All Recent SEC Filings |
26-Jun-2012
Entry into a Material Definitive Agreement, Financial Statements and Exh
On June 22, 2012, Coronado Biosciences, Inc., a Delaware corporation (the "Company"), entered into an underwriting agreement (the "Underwriting Agreement") with Oppenheimer & Co. Inc. and Roth Capital Partners, LLC, as co-representatives of the underwriters named therein (collectively, the "Underwriters"), pursuant to which the Company agreed to sell to the Underwriters an aggregate of 5,750,000 shares of common stock (the "Shares") at a public offering price of $5.00 per share (the "Offering"). The Shares include 750,000 shares of common stock subject to the over-allotment option granted to the Underwriters, which option was exercised in full on June 25, 2012. The Underwriters will purchase the Shares at a six and one-half percent discount of the public offering price, for an aggregate discount of $1,868,750. The Offering is expected to close on June 27, 2012, subject to customary closing conditions. The Company expects that the net proceeds of the Offering will be approximately $26.5 million after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. The Shares are being issued pursuant to a registration statement on Form S-1 (File No. 333-181856) declared effective by the Securities and Exchange Commission on June 21, 2012.
This description of the Offering is a summary only, is not intended to be complete, and is qualified in its entirety by reference to the Underwriting Agreement, which is attached as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated herein by reference.
On June 22, 2012, the Company issued a press release announcing the Offering. A copy of the press release is included as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
(d) Exhibits
1.1 Underwriting Agreement dated June 22, 2012 by and between the Company, Oppenheimer & Co. Inc. and Roth Capital Partners, LLC.
99.1 Press Release dated June 22, 2012.
|
|